Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 3,000 MLYS shares, $36.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 3,000 | $36.1K |
| Jun 18, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 3,000 | $36.1K |
| May 29, 2026 | COMPASS Pathways plc (CMPS) | Grant/Award | 21,110 | n/a |
| Apr 2, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 3,000 | $36.1K |
| Feb 21, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 6,200 | n/a |
| Nov 14, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 15,000 | $153.0K |
| Jun 13, 2025 | COMPASS Pathways plc (CMPS) | Grant/Award | 26,000 | n/a |
| Feb 24, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 32,900 | n/a |
| May 23, 2024 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 22,000 | n/a |
| May 13, 2024 | COMPASS Pathways plc (CMPS) | Grant/Award | 26,000 | n/a |